Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201404101856N4Phase 3Completed
Phase 3 trial of methylphenidate in ischemic stroke, sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Motor function improvement. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201404101856N4.